SMS Lifesciences India Ltd
Thu 13/03/2025,15:47:44 | NSE : SMSLIFE
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1050.05
Previous Close
₹ 1054.75
Volume
578
Mkt Cap ( Rs. Cr)
₹317.48
High
₹ 1068.05
Low
₹ 1050.00
52 Week High
₹ 1749.65
52 Week Low
₹ 589.20
Book Value Per Share
₹ 621.11
Dividend Yield
0.14
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on SMS Lifesciences India Ltd
Your Vote -
Buy
77.27%
Hold
18.18%
Sell
4.55%
77.27%
22 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts SMS Lifesciences India Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
SMS Lifesciences Ind - Updates
-
SMS Lifesciences Ind - Shareholders Queries (Weblink)
-
SMS Lifesciences Ind - Updates
-
SMS Lifesciences Ind - Shareholders meeting
-
SMS Lifesciences Ind - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
SMS Lifesciences Ind - Credit Rating
-
SMS Lifesciences Ind - Announcement under Regulation 30 (LODR)-Credit Rating
-
SMS Lifesciences Ind - Copy of Newspaper Publication
-
SMS Lifesciences Ind - Newspaper Publication (Financial Results)
-
SMS Lifesciences Ind - General Updates
-
SMS Lifesciences Ind - Sub-Committees Of Board (Reconstitution)
-
SMS Lifesciences Ind - Updates
-
SMS Lifesciences Ind - Integrated Filing- Financial
-
SMS Lifesciences Ind - Independent Directors Meeting
-
SMS Lifesciences Ind - Integrated Filing (Financial)
-
SMS Lifesciences Ind Q3 net profit jumps 88.22% at Rs 6.23 cr
-
SMS Lifesciences Ind - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
SMS Lifesciences Ind - Appointment
-
SMS Lifesciences Ind - Appointment Of Women Independent Director
-
SMS Lifesciences Ind - Appointment
-
SMS Lifesciences Ind - Reappointment Of Managing Director
-
SMS Lifesciences Ind - Financial Result Updates
-
SMS Lifesciences Ind - Outcome of Board Meeting
-
SMS Lifesciences Ind - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2024
-
SMS Lifesciences Ind - Board Meeting Outcome for Outcome Of 92Nd Board Meeting.
-
SMS Lifesciences Ind - Board Meeting Intimation for Meeting Scheduled To Be Held On Feb 12, 2025.
-
SMS Lifesciences Ind - Board Meeting Intimation
-
SMS Lifesciences Ind - Copy of Newspaper Publication
-
SMS Lifesciences Ind - Newspaper Publication (Postal Ballot)
-
SMS Lifesciences Ind - Shareholders meeting
-
SMS Lifesciences Ind - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
SMS Lifesciences Ind - Notice Of Shareholders Meetings-XBRL
-
SMS Lifesciences Ind - Disclosure of material issue
-
SMS Lifesciences Ind - USFDA Update (Material Subsidiary)
-
SMS Lifesciences Ind - General Updates
-
SMS Lifesciences Ind - Events Calendar (Postal Ballot)
-
SMS Lifesciences Ind has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
SMS Lifesciences Ind - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
SMS Lifesciences Ind - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
SMS Lifesciences Ind - General Updates
-
SMS Lifesciences Ind - Temporary Withheld Of Dividend.
-
SMS Lifesciences Ind - Trading Window-XBRL
-
SMS Lifesciences Ind - Trading Window
-
SMS Pharma receives non-exclusive license to manufacture & supply Molnupiravir
Key fundamentals
Evaluate the intrinsic value of SMS Lifesciences India Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 264.957 | 249.1726 | 210.9553 | 168.1632 | 157.8807 |
Liabilities | 264.957 | 249.1726 | 210.9553 | 168.1632 | 157.8807 |
Equity | 3.0233 | 3.0233 | 3.0233 | 3.0233 | 3.0233 |
Gross Profit | 34.4313 | 26.4065 | 31.3647 | 29.7351 | 23.7873 |
Net Profit | 13.0654 | 13.2176 | 25.3813 | 13.1683 | 9.1473 |
Cash From Operating Activities | 14.7514 | 4.5753 | -14.6554 | 21.6184 | 13.9491 |
NPM(%) | 4.35 | 4.19 | 7.34 | 5.05 | 3.56 |
Revenue | 300.0016 | 315.2418 | 345.6281 | 260.2555 | 256.9242 |
Expenses | 265.5703 | 288.8353 | 314.2634 | 230.5204 | 233.1369 |
ROE(%) | 6.95 | 7.03 | 13.51 | 7.01 | 4.87 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
23 Sep 2024 | 1.5 | 15 | 0.14 | 696.3 |
22 Sep 2022 | 1.5 | 15 | 0.14 | 637.6 |
20 Sep 2021 | 1.5 | 15 | 0.14 | 659.8 |
19 Sep 2019 | 1.5 | 15 | 0.14 | 483.4 |
Peers
Other companies within the same industry or sector that are comparable to SMS Lifesciences India Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 808.20 | -1.14 | 11.41 | 599.28 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 2183.72 | 14.01 | 0.88 |
Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 1125.57 | 2.31 | 0.00 |
Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 2059.06 | -239.30 | 0.00 |
Company Info
SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.
SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.
Read More
Parent Organisation
SMS Lifesciences India Ltd.
Founded
31/05/2006
Managing Director
Mr.TVVSN Murthy
NSE Symbol
SMSLIFEEQ
FAQ
The current price of SMS Lifesciences India Ltd is ₹ 1050.10.
The 52-week high for SMS Lifesciences India Ltd is ₹ 1068.05 and the 52-week low is ₹ 1050.00.
The market capitalization of SMS Lifesciences India Ltd is currently ₹ 317.48. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy SMS Lifesciences India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in SMS Lifesciences India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase SMS Lifesciences India Ltd shares.
The CEO of SMS Lifesciences India Ltd is Mr.TVVSN Murthy, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.